Duke Medical Center to Use Wafergen System in Genotyping Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Duke University Medical Center researchers will use WaferGen's real-time PCR system to conduct genotyping studies aimed at discovering genetic variants linked to breast cancer, the company said today.

Under the agreement, scientists in the Institute for Genome Sciences and Policy will conduct genotyping studies with the SmartChip Real-Time PCR system to validate nucleotide polymorphisms associated with breast cancer, and will study the impact those variants have on disease prognosis and response to treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.

Sep
10
Sponsored by
Qiagen

In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples. 

Sep
24
Sponsored by
Personalis

This online seminar will outline a targeted enrichment technology to improve next-generation sequencing assays for cancer research and clinical applications. 

Oct
07
Sponsored by
Personal Genome Diagnostics

This webinar will highlight the key considerations and applications of next-generation sequencing for managing non-small cell lung cancer patients using plasma-based approaches.